Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes

Diabetes Care- United States

doi 10.2337/dc12-2410

Full Text

Abstract

Available in

Date

Authors

Publisher

American Diabetes Association


Related search